Clinical Trials on Cytomegalovirus Infections in United States

Total 20268 results

University of Pennsylvania
Merck Sharp & Dohme LLC

Recruiting

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Cytomegalovirus Infections | Transplant-Related Disorder

United States
University of Wisconsin, Madison

Terminated

A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients

Cytomegalovirus Infections | Solid Organ Transplant

United States
Ionis Pharmaceuticals, Inc.

Completed

A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Mari Dallas

Recruiting

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Cytomegalovirus Infections | Opportunistic Infections | Hematopoietic Stem Cell Transplant

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the Artus® CMV PCR Test (CMV)

Cytomegalovirus Infections

United States
Ionis Pharmaceuticals, Inc.

Completed

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

HIV Infections | Cytomegalovirus Retinitis

United States
Hoffmann-La Roche

Completed

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Hoffmann-La Roche

Completed

A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Hoffmann-La Roche

Completed

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

HIV Infections | Cytomegalovirus Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

HIV Infections | Cytomegalovirus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

HIV Infections | Cytomegalovirus Retinitis

United States
Roche Global Development

Completed

A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Tufts Medical Center

Recruiting

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Neutropenia | Cytomegalovirus Infections | Infection in Solid Organ Transplant Recipients | Antiviral Toxicity

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Influence of Chronic CMV Infection on Influenza Vaccine Responses (SLVP025)

Influenza | Cytomegalovirus Infections

United States
Astra USA

Completed

Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

HIV Infections | Hypocalcemia | Cytomegalovirus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

HIV Infections | Cytomegalovirus Infections

United States
Beckman Coulter, Inc.

Terminated

Clinical Performance Evaluation of DxN CMV Assay

Cytomegalovirus

United States
SpyBiotech Limited

Recruiting

A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (SPYVAC01)

Cytomegalovirus Infections

United Kingdom
University College, London
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

CMV Glycoprotein B Vaccine in Allograft Recipients

Cytomegalovirus Infections

United Kingdom
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes. (ELICIT)

HIV Infections | Cytomegalovirus | CMV

United States
Hoffmann-La Roche

Completed

A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients

Cytomegalovirus Infections

Spain, France, Germany, Mexico, United States, Australia, Canada
National Eye Institute (NEI)

Completed

Efficacy of Elevated CD4 Counts on CMV Retinitis

Acquired Immunodeficiency Syndrome | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

HIV Infections | Cytomegalovirus Infections

United States, Puerto Rico
Sumithira Vasu

Recruiting

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Cytomegalovirus | Adenovirus | Donor | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Solid Organ Transplantation Recipient

United States
GlaxoSmithKline

Active, not recruiting

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Cytomegalovirus Infections

United States
Hoffmann-La Roche

Completed

A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls

Cytomegalovirus Infections

United States, Mexico
University of Alabama at Birmingham

Completed

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Cytomegalovirus Infections

United States
AlloVir

Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

United States
Stony Brook University
Frontier Science & Technology Research Foundation, Inc.

Recruiting

Long-Term Outcomes of Children With Congenital CMV in New York State (PROACTIVE NYS)

Sensorineural Hearing Loss | Congenital CMV Infection

United States
Sandoz

Completed

A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
St George's, University of London
European Society for Paediatric Infectious Diseases

Recruiting

Observational Study of the Management of Infants With Congenital CMV (cCMVnet)

Congenital Cmv

United Kingdom
University College, London

Suspended

Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (CMV_TCR-001)

CMV Infection | Haematological Malignancies

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection

HIV Infections | Cytomegalovirus Infections | Pneumonia, Pneumocystis Carinii | Cytomegalovirus Retinitis

United States
Hoffmann-La Roche

Completed

IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients (IMPACT)

Cytomegalovirus Infections

United States, Belgium, United Kingdom, Canada, France, Spain, Brazil, Australia, Germany, Italy, Romania, New Zealand, Poland
Shire

Completed

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

Cytomegalovirus Infections

United States
Shire

Completed

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Cytomegalovirus Infections

United States, Canada, United Kingdom, Germany, France, Belgium, Italy, Spain, Sweden
AlloVir

Terminated

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

Korea, Republic of, United States, Spain, France, Turkey, Australia, United Kingdom, Italy, Canada, Belgium
Hoffmann-La Roche

Completed

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

Cytomegalovirus Infections

Spain, Australia, Ireland, India, Italy, Canada, Belgium, Switzerland, Estonia, Austria, United Kingdom, Brazil, Mexico, Norway, Latvia, Turkey, Croatia, Serbia, Poland, New Zealand, Venezuela
Michael Pulsipher, MD

Active, not recruiting

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES)

Cytomegalovirus Infections | EBV Infection | Adenovirus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Cytomegalovirus

United Kingdom, United States, Canada
University of California, San Francisco
Roche Pharma AG

Completed

Valganciclovir to Reduce T Cell Activation in HIV Infection

HIV Infections | Cytomegalovirus Infections

United States
University of North Carolina, Chapel Hill

Completed

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

Burns | Cytomegalovirus

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

Coronary Disease | Arterial Occlusive Diseases | Atherosclerosis | Cytomegalovirus Infections

United States
University College, London

Completed

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Viraemia

United Kingdom
Milton S. Hershey Medical Center
National Cancer Institute (NCI)

Unknown

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Cancer

United States
University Hospital Birmingham

Unknown

T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

Graft Versus Host Disease | Nonneoplastic Condition

United Kingdom
Professor Lorraine Harper
Wellcome Trust

Unknown

CMV Modulation of the Immune System in ANCA-associated Vasculitis (CANVAS)

ANCA Associated Vasculitis | CMV Infection

United Kingdom
Johns Hopkins Bloomberg School of Public Health
National Eye Institute (NEI)

Completed

Longitudinal Study of Ocular Complications of AIDS (LSOCA) (LSOCA)

HIV Infections | Acquired Immunodeficiency Syndrome | Cytomegalovirus Retinitis

United States
Sandoz

Completed

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

HIV Infections | Cytomegalovirus Infections

United States

Clinical Trials on Cytomegalovirus Infections in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations